Browsing: Investments
The bullish thesis on Nvidia remains in place ahead of earnings, but analysts have questions about the company’s path forward.…
Investors are underappreciating the effect generative artificial intelligence will have on biotech stocks, according to Jefferies. Biotech stocks have had…
Nvidia is set to report its latest quarterly results after the bell on Wednesday, and there are certain stocks besides…
With the technology sector gaining momentum again amid a broader market recovery, Adobe stands out as a high-quality growth stock…
Amazon and Google parent Alphabet are among Goldman Sachs’ top picks in the internet segment to rebound in the second…
(This is a wrap-up of the key money moving discussions on CNBC’s “Worldwide Exchange” exclusive for PRO subscribers. Worldwide Exchange…
Here are Wednesday’s biggest calls on Wall Street: Truist initiates Teva as buy Truist said Teva is best positioned to…
Regulatory risks looming over Fair Isaac are overblown, according to Baird. The investment firm upgraded the credit scoring firm to…
Owning Booz Allen Hamilton at current levels no longer makes sense, according to Goldman Sachs. The bank downgraded shares of…
Teva is positioning itself well for sharp gains in the near future after a decline this year, according to Truist…